Quetiapine - Bipolar disorder (adults)
You are here : Home > Formulary Search > Quetiapine - Bipolar disorder (adults)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Immediate release tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Preferred
Initiation and stabilisation by a SABP specialist for a minimum of 3 months before any request for transfer of prescribing responsibility.
Status 2
Red
Formulations :
- Modified release tablets
Formulary Status :
Associated Icons :
R
SPC
Restrictions / Comments :
Important
Modified release tablets are reserved for use when immediate release tablets are not suitable.
Modified release quetiapine MAY be continued in Primary Care (after a 3-month period of stabilisation by SABP) where the use of immediate release tablets would risk destabilising the patient.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Quetiapine
Indication :
Bipolar disorder (adults)
Group Name :
Keywords :
mania, bipolar with depression, bipolar with mania
Brand Names Include :
Important Information :
For bipolar with mania / depression.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Quetiapine is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Bipolar disorder (adults).
Committee Recommendations (0)
- No records returned.